Novartis is reshuffling its cards in Switzerland. To cover new drug launches, both
branded and generic, the company is cutting 500 jobs in its pharma division and
hiring up elsewhere. It's the latest job-trimming move at the Swiss drugmaker,
which has shed thousands of jobs over the last several years.
Μπορείτε να στέλνετε ειδήσεις και Δελτία Τύπου στο email μας.
Αν θέλετε να επικοινωνήσετε μαζί μας ή να στείλετε Δελτίο Τύπου πατήστε εδώ...pharmamarketingexpertsblog@gmail.com
Αν θέλετε να επικοινωνήσετε μαζί μας ή να στείλετε Δελτίο Τύπου πατήστε εδώ...pharmamarketingexpertsblog@gmail.com
Τετάρτη 22 Ιανουαρίου 2014
Four Effective Ways to Enrich Your Career as a Pharmaceutical Representative
You were attracted to the
pharmaceutical industry because of the perks of being a representative: you get
to travel across the country helping people treat, manage and cure illnesses
and conditions. The job relies on your salesmanship and knowledge of the
industry. Get a leg up on colleagues and others vying for the same jobs and
promotions in the industry by becoming a more knowledgeable, experienced
salesperson in the field.
Earn Your
Masters
Earn a graduate degree and
become more qualified for a better salary and a promotion. There are a number
of fields in which a pharmaceutical sales representative could thrive, such as
business and marketing, but there are a few more outside of the box, too. Opt
for a specialization such as healthcare ethics and join the debate on ethics in
the medical field.
Johnson and Johnson Out Ranks All Other Pharma Companies in Social Media Engagement, According to IMS
According to a new report released today by the IMS Institute for
Healthcare Informatics, nearly half of pharmaceutical companies are now
actively using social media -- specifically Facebook, Twitter and YouTube -- to
"engage with patients on healthcare-related topics".
IMS
points out that only ten companies utilize all three of these major social
networking services for healthcare topics. "Many companies are using
social media primarily as a unilateral broadcasting channel to physicians and
patients, with limited interaction or fostering of discussion," says IMS.
Εγγραφή σε:
Αναρτήσεις (Atom)